Year: 2020
Type: review
Abstract: There is an increasing role for biological markers (biomarkers) in the understanding and diagnosis of neurodegenerative disorders. The application of imaging biomarkers specifically for the in vivo investigation of neurodegenerative disorders has increased substantially over the past decades and continues to provide further benefits both to the diagnosis and understanding of these diseases. This review forms part of a series of articles which stem from the University College London/University of Gothenburg course "Biomarkers in neurodegenerative diseases". In this review, we focus on neuroimaging, specifically positron emission tomography (PET) and magnetic resonance imaging (MRI), giving an overview of the current established practices clinically and in research as well as new techniques being developed. We will also discuss the use of machine learning (ML) techniques within these fields to provide additional insights to early diagnosis and multimodal analysis.
Source: Alzheimer s Research & Therapy
Authors: Peter N. E. Young, Mar Estarellas, Emma Coomans, Meera Srikrishna, Helen Beaumont, Anne Maass, Ashwin V. Venkataraman, Rikki Lissaman, Daniel Jiménez, Matthew J. Betts, Eimear McGlinchey, David Berron, Antoinette O’Connor, Nick C. Fox, Joana B. Pereira, William Jagust, Stephen F. Carter, Ross W. Paterson, Michael Schöll
Institutions: Sahlgrenska University Hospital, Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, University College London, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, University of Manchester, German Center for Neurodegenerative Diseases, UK Dementia Research Institute, Imperial College London, Cardiff University, UCL Queen Square Institute of Neurology, University of Chile, Otto-von-Guericke-Universität Magdeburg, Trinity College Dublin, Lund University, Karolinska Institutet, Lawrence Berkeley National Laboratory, University of California, Berkeley, University of Cambridge, Manchester Academic Health Science Centre
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,170
Funders: Rosetrees Trust, Göteborgs Universitet
Award: G8452586996
OpenAlex ID: W3018148317
